Induction of human immunodeficiency virus (HIV-1) envelope specific cell-mediated immunity by a non-homologous synthetic peptide

PLoS ONE

Volumn 2, Issue 11, 2007, Pages

  Achour, Ammar ^a   Biquard, Jean Michel ^a   Krsmanovic, Velibor ^b   M'Bika, Jean Pierre ^a   Ficheux, Damien ^c   Sikorska, Marianna ^d   Cozzone, Alain J ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ LYON 1   (France)

^c University Lyon i   (France)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENVELOPE PROTEIN; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE CA1; SYNTHETIC PEPTIDE; TRANSACTIVATOR PROTEIN; VACCINIA VACCINE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA STRAND; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; NONHUMAN; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RABBIT; SEQUENCE ANALYSIS; VIRUS CELL TRANSFORMATION; VIRUS IDENTIFICATION; ANIMAL; CASE CONTROL STUDY; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PHENOTYPE; PHYSIOLOGY; SERODIAGNOSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANIMALS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENE PRODUCTS, ENV; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHENOTYPE; RABBITS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 43249100592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001214     Document Type: Article

References (57)

1. Cao Y, Quin L, Zhang J, Safrit R, Ho DD (1995) Virologic and immunologic characterization of long-term survivors of Human Immunodeficiency Virus type I Infection. New England Journal of Medicine 322: 201-207.
2. Matano T, Shibata R, Siemon C, Connors M, Lane HC, et al. (1998) Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 72: 164-169.
3. Schmitz JE, Kuroda MJ, Santra S, Sasseville VC, Simon MA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
4. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, et al. (1999) Dramatic rise in plasma viremia after CD8 [+] T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189: 991-998.
5. Barouch DH, Kunstman J, Kuroda MJ, Schmitz JE, Santra S, et al. (2002) Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415: 335-339.
6. Letvin NL, Mascola JR, Sun Y, Gorgone DA, Buzby AP, et al. (2006) Preserved CD4+ central memory T cells and survival in vaccinated SIV challenged monkeys. Science 312: 1530-1533.
7. Townsend ARM, Rothbard J, Gotch FM, Bahadur G, et al. (1986) The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959-968.
8. Gotch F, McMichael AJ, Smith G, Moss B (1986) Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Me 165: 408-413.
9. Takahashi H, Houghten R, Putney SD, Margulies DH, Moss B, et al. (1989) Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T-cell recognition of an immunodominant epitope of the human immunodeficiency virus envelope protein. J Exp Med 170: 2023-2035.
10. Eisenberg D, Weiss RM, Terwilliger TC (1984) The hydrophobic moment detects periodicity in protein hydrophobicity. Proc Natl Acad Sci USA 81: 140-144.
11. Cornette JL, Cease KB, Margalit H, Sponge JL, Berzofsky JA, et al. (1987) Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. J Mol Biol: 195: 659-685.
12. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.
13. Nakai K, Kidera A, Kanehisa M (1988) Cluster analysis of aminoacid indices for prediction of protein structure and fonction. Protein Eng 2: 93-100.
14. Parker JMR, Guo D, Hodges RS (1986) New hydrophilicity derived from high-performance liquid chromatography peptide retention data :correlation of predicted surface residues with antigenicity and X-ray derived accessible sites. Biochemistry 25: 5425-5432.
15. Engelman DM, Steitz TA, Goldman A (1986) Idenfifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Ann Rev Biophys Biophys Chem 15: 321-353.
16. Finer-Moore J, Stroud RM (1984) Amphipathic analysis and possible formation of the ion channel in an acetylcholinereceptor. Proc Natl Acad Sci. USA 81: 155-159.
17. Finer-Moore J, Bazan JF, Rubin J, Stroud RM (1989) Prediction of Protein Structure and the Principles of Protein Conformation. In: Fasman GD, ed. New York Plenum Press. pp 193-316.
18. McLachlan AD, Kahn J (1983) Periodic features in the aminoacid sequence of nematode myosin rod. J Mol. Biol 164: 605-626.
19. Bohr H, Bohr J, Brunak S, Cotterill R, Lautrup B, Norskov, et al. (1988) Protein secondary structure and homology by neural networks. The alpha-helices in rhodopsin. FEBS Lett 241: 223-228.
20. Bork P, Grunwald C (1990) Recognition of different nucleotide-binding sites in primary structures using a property pattern approach. Eur J Biochem 191: 347-358.
21. Jameson BA, Wolf H (1988) The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl BioSci 4: 181-186.
22. Hertz GZ, Hartzell GW, Stormo GD (1990) Identification of consensus patterns in malignant DNA sequences known to be functionally related. Comput Appl Bio Sci. 6: 81-92.
23. Richards FM, Kundrot CE (1988) Identification of structural motifis from protein coordinate data: secondary structure and first level supersecondary structure Proteins 3: 71-84.
24. Heine V, Koen M, Uir D (1973) In Theory of Pseudopotentials. MIR Moscow.
25. Veljkovic V (1980) A Theoretical Approach to Preselection of Carcinogens and Chemical Carcinogenesis. New York: Gordon Breach.
26. Veljkovic V, Slavic I (1972) Simple general-model pseudopotential. Phys Rev Lett 29: 105-107.
27. Cosic I (1990) Resonant recognition model of protein-protein and protein-DNA interaction, in Bioinstrumentation and Biosensors. In Wise D, ed. New York: Marcel Dekker: 475.
28. Cosic I, Nesic D, Pavlovic M, Williams R (1986) Enhancer binding proteins predicted by informational spectrum method. Biochem Biophys Res Commun 141: 831.
29. Veljkovic V, Cosic I (1987) A novel method of protein analysis for prediction of biological function. Cancer Biochem Biophys 9: 139.
30. Cosic I, Drummond AE, Underwood JR, Hearn MT (1994) In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide. Mol Cell Biochem 130: 1-9.
31. Ivanovic V, Demajo M, Todorovic-Rakovic N, Nikolic-Vukosavljevic D, Neskovic-Konstantinovic Z, et al. (2004) Localization of recognition site between transforming growth factor-b1 [TGF-b1] and TGFb-receptor type II: possible implications in breast cancer. Med Hypoth 62: 727-730.
32. Cosic I, Hodder AN, Aguilar MI, Hearn MT (1991) Resonant recognition model and protein topography. Model studies with myoglobin, hemoglobin and lysozyme. Eur J Biochem 198: 113-119.
33. Cosic I, Hearn MT (1992) Studies on protein-DNA interactions using the resonant recognition model. Application to repressors and transforming proteins. Eur J Biochem 205: 613-619.
34. Krsmanovic V, Biquard JM, Sikorska-Walker M, Cosic I, Desgranges C, et al. (1998) Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived front HIV-1 gp 120 proteins. J Pept Res 52: 410-420.
35. Biquard JM, Mbika JP, Krasmanovic V, Achour A (2003) Ability to generate synthetic peptides that immunologically mimic HIV-1 tat regulatory protein. AIDS 17: 2001-2002.
36. Meckler LB (1969) Specific selective interactions between amino acid residues of peptide chains. Biofizika 14: 581-584.
37. Biro J (1981) The complementary coding of some proteins as the possible source of specificity in protein-protein interactions. Med Hypothesis 7: 981-993.
38. Biro J (1981) Models of gene expression based on the sequential complementary coding of some pituitary proteins. Med Hypothesis 7: 995-1007.
39. Blalock JE, Smith EM (1984) Hydropathic anti-complementarity of amino acids based on the genetic code. Biochem Biophys Res Commun 121: 203-207.
40. Merino E, Balbas P, Puente JL, Bolivar F (1994) Antisense overlapping open reading frames in genes for bacteria to humans. Nucleic Acids Res 22: 1903-1908.
41. Blalock JE, Bost KL (1986) The binding of peptides that are specified by complementary RNAs. Biochem J 234: 679-683.
42. Blalock JE (1990) Complementarity of peptides specified by "sense" and "antisense" strands of DNA. Trends Biotechnol 8: 140-144.
43. Clarke BL, Blalock JE (1991) Characteristics of peptides specified by antisense nucleic acids. In: Mol JNM, Van der Krol A, eds. Antisense Nucleic Acids and Proteins. Basel: M. Dekker Inc. pp 169-185.
44. Tropsha A, Kizer JS, Chaiken IM (1992) Making sense of antisense: a review of experimental data and developing ideas on sense-antisense peptide recognition. J Molec Recog 5: 43-54.
45. Forsdyke DR (1995) Sense in antisense? Journal of Molecular Evolution 41: 582-586.
46. Bost KL, Smith EM, Blalock JE (1985) Regions of complementarity between the messenger RNAs for epidermal growth factor, transferring, interleukin-2 and their respective receptors. Biochem Biophys Res Common 128: 1373-1380.
47. Sunnarborg A, Klumpp D, Chung T, LaPorte DC (1990) Regulation of the glyoxylate bypass operon: cloning and characterization of icIR. J Bacteriol 172: 2642-2649.
48. Achour A, Picard O, Mbika JP, Willer A, Snart R, et al. (1993) Envelope protein and P18IIIB peptide recognized by cytotoxic T lymphocytes from humans immunized with Aids virus Envelope. Vaccine 11: 699-701.
49. Achour A, Lemhamedi S, Picard O, Mbika JP, Zagury JF, et al. (1994) Cytotoxic T Lymphocytes Specific for HIV-1 gp160 Antigen and Synthetic P18IIIB Peptide in an HLA-A11-Immunized Individual. Aids Res Hum Retroviruses 10: 19-25.
50. Bex F, Hermans P, Sprecher S, Achour A, Badjou R, et al. (1994) Therapeutic vaccination against AIDS in identical twins. Blood 84: 3317-3326.
51. Picard O, Achour A, Bernard J, Halbreich A, Bizzini B, et al. (1992) A 2 years follow up of anti-HIV immune reaction in HIV-1 gp160 immunized healthy seronegative humans: evidence for persistent cell mediated immunity. J AIDS 5: 539-546.
52. Achour A, Bex F, Hermans P, Burny A, Zagury D (1996) Induction of anti-gp160 cytotoxic T cells cross-reacting with various V3 loop P18 peptides in human immunodeficiency virus type 1 envelope-immunized individuals. J Virology 70: 6741-6750.
53. Achour A, Lu W, Arlie M, Cao L, Andrieu JM (2003) T Cell Survival/ Proliferation Reconstitution by Trifluoperazine in Human Immunodeficiency Virus-1 Infection. Virology 315: 245-258.
54. Achout A, Picard O, Zagury D, Sarin PS, Gallo RC (1990) HGP30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc Natl Acad Sci USA 87: 7045-7049.
55. Rammensee HG, Falk K, Rotzschke O (1993) Peptides naturally presented by MHC class I molecules. Anim Rev Immunol. 11: 213-44.
56. Rammensee HG, Bachmann J, Emmerich NN, Bachor CA, Stevanovic S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219 (access via: www.syfpeithi.de).
57. Kenneth C, Parker M, Bednarek A, Hull LK, et al. (1992) Sequence motifs important for peptide binding to the human MHC Class I molecule, HLA-A2. J Immunol 149: 2560-358.